Sun, Apr 23, 2017 | updated 09:20 PM IST

Immunotherapy doubles survival of head, neck cancer patients

Updated: Oct 09, 2016 13:52 IST      
Immunotherapy doubles survival of head, neck cancer patients

New Delhi [India], Oct. 9 (ANI): An immunotherapy drug has been hailed as a potential 'game changer' after being found to greatly improve survival for patients with relapsed head and neck cancer.

Nivolumab became the first treatment to extend survival in a phase III clinical trial for patients with head and neck cancer in whom chemotherapy had failed and it did so with fewer side-effects than existing therapeutic options, says a new research.

More than double the number of patients taking nivolumab were alive after one year as those treated with chemotherapy.

There are currently no other treatment options that improve the survival of patients with cisplatin-resistant relapsed or metastatic head and neck cancers.

This group of patients is expected to live less than six months.

The trial was led in the UK by Professor Kevin Harrington and involved 20 research organisations from around the world.

static head and neck cancer were allocated to receive nivolumab and 121 to one of three different chemotherapies.

UK patients received the chemotherapy drug docetaxel, which is the only treatment approved for advanced head and neck cancer by NICE.

After one year of the study, 36 percent of patients treated with nivolumab were still alive compared with 17 percent for the comparator arm.

Median survival for patients on nivolumab was 7.5 months, compared with 5.1 months for chemotherapy.

The survival benefit was more pronounced in patients whose tumours had tested positive for human papillomavirus (HPV).

These patients survived an average of 9.1 months with nivolumab and 4.4 months with chemotherapy.

HPV-negative patients survived an average of 7.5 months with nivolumab and 5.8 with chemotherapy.

Importantly, fewer patients experienced serious side-effects from taking nivolumab than with conventional treatment, only 13 percent compared with 35 percent of patients, who received chemotherapy.

Patients given chemotherapy reported feeling physically, socially and emotionally worse off, whereas those who were given nivolumab remained stable during the course of treatment.

Harrington said: "Nivolumab could be a real game-changer for patients with advanced head and neck cancer.

This trial found that it can greatly extend life among a group of patients who have no existing treatment options, without worsening quality of life."

"Once it has relapsed or spread, head and neck cancer is extremely difficult to treat. So it's great news that these results indicate we now have a new treatment that can significantly extend life, and I'm keen to see it enter the clinic as soon as possible," he added.

The research has been published in New England Journal of Medicine. (ANI)

Washington D.C. [USA], Apr 23 (ANI): A recent study has demonstrated that in the general population, central obesity, insulin resistance, diabetes, lipid abnormalities and high alcohol consumption were the strongest predictors of severe liver disease.

Full Story >>

Breastmilk may help detect your cancer risk

Updated: Apr 23, 2017 11:50 IST

Washington D.C. [USA], Apr 23 (ANI): Breastmilk might offer clues about a woman's cancer risk, according to a recent research.

Full Story >>

Soon, new weapon in war against obesity

Updated: Apr 23, 2017 11:14 IST

Washington D.C. [USA], Apr 23 (ANI): A team of scientists has uncovered a potential approach to combat obesity.

Full Story >>

Turns out, being obese is worse than smoking

Updated: Apr 23, 2017 10:52 IST

Washington D.C. [USA], Apr 23 (ANI): You may want to shed those extra kilos as a recent study has found obesity as a top cause of preventable life-years lost.

Full Story >>

Washington D.C. [USA], Apr 23 (ANI): Testing for molecular markers in the urine of kidney transplant patients could reveal whether the transplant is failing and why, according to a recent research.

Full Story >>

Washington D.C. [USA], Apr 23 (ANI): People with drug-resistant bacteria in their urine or stool samples are at an increased risk of developing Sepsis, a bloodstream infection that is also resistant to certain antibiotics, according to a recent study.

Full Story >>

Move over contact lenses, LASIK is better

Updated: Apr 22, 2017 18:05 IST

Washington D.C. [USA], April 22 (ANI): Good news for those who underwent LASIK (laser-assisted in situ keratomileusis) for correction of their vision, as a recent study has found that the rate of cornea infection is lower.

Full Story >>

New Delhi [India], Apr. 22 (ANI): In today's era of booming medical advancements, the chances of survival from cancer can be increased, if it is detected at an early stage.

Full Story >>

Eman Ahmed has done miraculously well: Doctor

Updated: Apr 21, 2017 21:11 IST

Mumbai (Maharashtra) [India], Apr 21 (ANI): 36-year-old Egyptian Eman Ahmed, who was the heaviest woman in the world at 500-plus kg until a few months ago, has lost 250kg in two months after undergoing surgery here at Saifee Hospital.

Full Story >>

Let's create awareness about liver cancer!

Updated: Apr 21, 2017 17:25 IST

New Delhi [India], Apr 21 (ANI): The increasing liver disease is one of the most common diseases in the world.

Full Story >>

College blues? Turn to mindfulness

Updated: Apr 21, 2017 16:35 IST

Washington D.C. [USA], Apr 21 (ANI): Heading off to college? A recent study has suggested that mindfulness may help freshmen stress less and smile more.

Full Story >>

Washington D.C. [USA], April 21 (ANI): A team of US researchers has revealed that the traditional clinical hearing tests often fail to diagnose patients with a common form of inner ear damage, which otherwise might be detected by some behavioural tests.

Full Story >>

Washington D.C. [USA], April 21 (ANI): Canadian researchers have found that people with multiple sclerosis start showing symptoms of something wrong, five years before the onset of disease.

Full Story >>

Washington D.C. [USA], Apr 20 (ANI): You may want to stimulate your brain in early life as a recent study has found that it may help stay mentally healthy in older age.

Full Story >>

New Delhi [India], Apr 20 (ANI): A 24-year-old multiple sclerosis patient recently got another chance at life after undergoing a bone marrow transplantation.

Full Story >>

A weapon against Alzheimer's in your womb?

Updated: Apr 20, 2017 17:13 IST

Washington D.C. [USA], Apr 20 (ANI): Think your memory is starting to slip? A protein found in umbilical cord blood may help turn back the clock on mental ageing.

Full Story >>

New Delhi [India], Apr 20 (ANI): Even though 91% Indians consider health a priority and intend to make healthy changes, a study suggests that almost one-third of the population does not care to visit physicians on time.

Full Story >>

Washington D.C. [USA], April 20 (ANI): Menopausal or pre- menopausal women, aged 40-65, who experience hot flashes or excessive sweating during sleep, are at increased risk of moderate and severe depression.

Full Story >>

New Delhi [India], Apr 19 (ANI): Tobacco is considered to be one of the most important avoidable lifestyle related cause of cancer in the world.

Full Story >>

New Delhi [India], Apr 19 (ANI): According to WHO, liver disease is the 10th most common cause of death in India.

Full Story >>